Trial NCT01090973

View at ClinicalTrials.gov 
Org. Study IDs: MCC-15971
Secondary IDs: CLBH589B25T IRB # Pro00000102

Last trial update was posted on 2013-12-16

MeSH Interventions

Histone Deacetylase Inhibitors Panobinostat

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Lymphoma, Mantle-Cell

Other Conditions

Non-Hodgkin's Lymphoma

Stopping Reasons

Pharmaceutical company request.

Limitations And Caveats

The study was abandoned after only one patient due to low accrual and the sponsor losing interest in the single-agent. The one patient had disease progression requiring more aggressive treatment and did not complete the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID